| ²é¿´: 696 | »Ø¸´: 8 | ||
| ±¾Ìû²úÉú 1 ¸ö ²©Ñ§EPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
zps1888Òø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖ°£ºÎÄÏ×È«ÎÄÏÂÔØ
|
|
|
¸÷λ´óÏÀ£¬²éºÃºóÇë·¢ ÓÊÏä rmrrtv@126.com ²é²»È«µÄÒ²¿ÉÒÔ£¬ºÃµÄ»°²¹·¢½ð±ÒŶ 1 Chemistry and biology of cyclic depsipeptides of medicinal and biological interest 2 New drugs from the sea 3 Recent developments in depsipeptide research 4 Use of angiogenesis inhibitors in tumour treatment 5 New drugs in cancer therapy Chemotherapeutic Strategies in the Challenge of Cancer Treatment 6 Marine-derived anticancer agents in clinical trials 7 Effect of Aplidin in acute lymphoblastic leukaemia cells 8 Pharmaceutical development of anticancer agents derived from marine sources 9 Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™ 10 Marine natural products and their potential applications as anti-infective agents 11 In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors: 12 Marine natural products 13 Natural products in anticancer therapy 14 The discovery and development of marine compounds with pharmaceutical potential 15 In vitro hematotoxicity of Aplidine on human bone marrow and cord blood progenitor cells 16 Marine genetic resources: A review of scientific and commercial interest 17 In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells 18 Degradation kinetics of aplidine, a new marine antitumoural cyclic peptide, in aqueous solution 19 Novel anti-cancer agents in development: exciting prospects and new challenges 20 Marine organisms as a source of new anticancer agents 21 Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4¡ä-hydrazino-2-stilbazole 22 Antitumor compounds from tunicates 23 Synthesis, Conformational Analysis, and Cytotoxicity of Conformationally Constrained Aplidine and Tamandarin A Analogues Incorporating a Spirolactam ¦Â-Turn Mimetic 24 Synthetic Studies of Tamandarin B Side Chain Analogues 25 Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials† 26 In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug 27 Drugs from the seas-current status and microbiological implications 28 Population pharmacokinetics meta-analysis of plitidepsin (Aplidin® in cancer subjects29 Nature: a vital source of leads for anticancer drug development |
» ²ÂÄãϲ»¶
085602µ÷¼Á ³õÊÔ×Ü·Ö335
ÒѾÓÐ5È˻ظ´
302·Ö 085601Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ8È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ10È˻ظ´
²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
085410È˹¤ÖÇÄÜ ³õÊÔ316·Ö Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
070300»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
318Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
315Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
¡¾·ÖÏí¡¿¾ÞÅ£×ܽ᣺¸ãÓлú±ØÐëѧ»áµÄºÏ³É¼ìË÷·½·¨
ÒѾÓÐ169È˻ظ´
zps1888
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 340.8
- É¢½ð: 500
- Ìû×Ó: 74
- ÔÚÏß: 24.2Сʱ
- ³æºÅ: 623260
- ×¢²á: 2008-10-11
- רҵ: ʳƷ¼Ó¹¤¼¼Êõ
5Â¥2011-06-16 16:55:12
beautybanana
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 23 (СѧÉú)
- ¹ó±ö: 0.02
- ½ð±Ò: 2973.8
- É¢½ð: 5088
- ºì»¨: 26
- Ìû×Ó: 1694
- ÔÚÏß: 485.8Сʱ
- ³æºÅ: 1142157
- ×¢²á: 2010-11-09
- ÐÔ±ð: GG
- רҵ: ÄÉÃ×ÉúÎïѧ
2Â¥2011-06-16 13:53:59
Èöµ°
ľ³æ (ÖøÃûдÊÖ)
ÌìÌÃÀïµÄ¶ñħ
- ²©Ñ§EPI: 1
- Ó¦Öú: 11 (СѧÉú)
- ½ð±Ò: 1000
- É¢½ð: 3732
- ºì»¨: 3
- ɳ·¢: 2
- Ìû×Ó: 2931
- ÔÚÏß: 501.6Сʱ
- ³æºÅ: 297102
- ×¢²á: 2006-11-18
- ÐÔ±ð: GG
- רҵ: °ëµ¼Ìå²ÄÁÏ
3Â¥2011-06-16 14:49:48
liunahan
ľ³æÖ®Íõ (ÎÄѧ̩¶·)
- ²©Ñ§EPI: 3
- Ó¦Öú: 118 (¸ßÖÐÉú)
- ½ð±Ò: 136744
- É¢½ð: 200
- ºì»¨: 40
- Ìû×Ó: 107032
- ÔÚÏß: 5508.2Сʱ
- ³æºÅ: 260314
- ×¢²á: 2006-06-17
- ÐÔ±ð: GG
- רҵ: µç»¯Ñ§

4Â¥2011-06-16 15:05:45














in cancer subjects
»Ø¸´´ËÂ¥